UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes

Frontiers in immunology, 2019-03, Vol.10, p.571-571

2019

Link zum Volltext

Verfügbarkeit prüfen

Using metformin in the presence of renal disease

BMJ (Online), 2015-04, Vol.350, p.h1758

2015

Link zum Volltext

Verfügbarkeit prüfen

Management of diabetes in people with advanced chronic kidney disease

Diabetic medicine, 2024-07, p.e15402

2024

Link zum Volltext

Verfügbarkeit prüfen

Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study

BMJ open, 2018-03, Vol.8 (3), p.e020145-e020145

2018

Link zum Volltext

Verfügbarkeit prüfen

Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London

BMC nephrology, 2017-06, Vol.18 (1), p.201-201, Article 201

2017

Link zum Volltext

Verfügbarkeit prüfen

Glucagon‐like peptide‐1 receptor analogues in renal transplant recipients with diabetes: Medium term follow of patients from a single UK centre

Diabetic medicine, 2023-05, Vol.40 (5), p.e15057-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Bruton's TK regulates macrophage NF‐κB and NLRP3 inflammasome activation in metabolic inflammation

British journal of pharmacology, 2020-10, Vol.177 (19), p.4416-4432

2020

Link zum Volltext

Verfügbarkeit prüfen

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A2 Proves Renal Origins of Urinary PGI-M and TX-M

Circulation research, 2018-02, Vol.122 (4), p.555-559

2018

Link zum Volltext

Verfügbarkeit prüfen

Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?

BMC nephrology, 2011-10, Vol.12 (1), p.55-55, Article 55

2011

Link zum Volltext

Verfügbarkeit prüfen

Could metformin be used in patients with diabetes and advanced chronic kidney disease?

Diabetes, obesity & metabolism, 2017-02, Vol.19 (2), p.156-161

2017

Link zum Volltext

Verfügbarkeit prüfen

Letter by Mitchell et al Regarding Article, “Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment”

Circulation research, 2018-05, Vol.122 (10), p.e84-e85

2018

Link zum Volltext

Verfügbarkeit prüfen

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Circulation research, 2018-02, Vol.122 (4), p.555-559

2018

Link zum Volltext

Verfügbarkeit prüfen

Managing diabetes in dialysis patients

Postgraduate Medical Journal, 2012-03, Vol.88 (1037), p.160-166

2012

Link zum Volltext

Verfügbarkeit prüfen

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis

Kidney international, 2008-10, Vol.74 (7), p.946-951

2008

Link zum Volltext

Verfügbarkeit prüfen

Managing blood glucose levels in patients with diabetes and renal impairment

British journal of hospital medicine (London, England : 2005), 2016-01, Vol.77 (1), p.C10

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin

Nature clinical practice. Nephrology, 2005-12, Vol.1 (2), p.87-97

2005

Link zum Volltext

Verfügbarkeit prüfen

Novel applications of recombinant erythropoietin

Current opinion in pharmacology, 2006-04, Vol.6 (2), p.184-189

2006

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Decline of GFR in Diabetic Nephropathy Predicted by Interferon Release Assay to Tuberculosis Antigens

Nephron, 2011-02, Vol.117 (3), p.c266-c269

2011

Link zum Volltext

Verfügbarkeit prüfen

Structural remodeling of resistance arteries in uremic hypertension

Kidney international, 2004-05, Vol.65 (5), p.1818-1825

2004

Link zum Volltext

Verfügbarkeit prüfen

Homocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEMPOL

Nephrology, dialysis, transplantation, 2004-08, Vol.19 (8), p.1999-2005

2004

Link zum Volltext

Verfügbarkeit prüfen

Cardio-renal interface in translational and clinical research

Current opinion in pharmacology, 2006-04, Vol.6 (2), p.121-124

2006

Link zum Volltext

Verfügbarkeit prüfen

PREVALENCE OF COGNITIVE IMPAIRMENT IN PATIENTS ATTENDING PRE-DIALYSIS CLINIC

Journal of renal care, 2008-09, Vol.34 (3), p.121-126

2008

Link zum Volltext

Verfügbarkeit prüfen

Race and sex: Predictors of the severity of hyperparathyroidism in peritoneal dialysis patients

Nephrology (Carlton, Vic.), 2006-02, Vol.11 (1), p.15-20

2006

Link zum Volltext

Verfügbarkeit prüfen

The myogenic response in uremic hypertension

Kidney international, 2003-02, Vol.63 (2), p.642-646

2003

Link zum Volltext

Verfügbarkeit prüfen

Flow induces dilatation in the femoral artery of uraemic rats but constriction in control rats

Nephrology, dialysis, transplantation, 2001-06, Vol.16 (6), p.1156-1162

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes

Using metformin in the presence of renal disease

Management of diabetes in people with advanced chronic kidney disease

Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study

Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London

Glucagon‐like peptide‐1 receptor analogues in renal transplant recipients with diabetes: Medium term follow of patients from a single UK centre

Inhibition of Bruton's TK regulates macrophage NF‐κB and NLRP3 inflammasome activation in metabolic inflammation

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A2 Proves Renal Origins of Urinary PGI-M and TX-M

Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?

Could metformin be used in patients with diabetes and advanced chronic kidney disease?

Letter by Mitchell et al Regarding Article, “Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment”

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A 2 Proves Renal Origins of Urinary PGI-M and TX-M

Managing diabetes in dialysis patients

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis

Managing blood glucose levels in patients with diabetes and renal impairment

Mechanisms of Disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin

Novel applications of recombinant erythropoietin

Accelerated Decline of GFR in Diabetic Nephropathy Predicted by Interferon Release Assay to Tuberculosis Antigens

Structural remodeling of resistance arteries in uremic hypertension

Homocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEMPOL

Cardio-renal interface in translational and clinical research

PREVALENCE OF COGNITIVE IMPAIRMENT IN PATIENTS ATTENDING PRE-DIALYSIS CLINIC

Race and sex: Predictors of the severity of hyperparathyroidism in peritoneal dialysis patients

The myogenic response in uremic hypertension

Flow induces dilatation in the femoral artery of uraemic rats but constriction in control rats

Suchergebnisse filtern